Phase I study of NTM 001 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 04 Sep 2019
Price : $35 *
At a glance
- Drugs Ketorolac (Primary) ; Ketorolac
- Indications Postoperative pain
- Focus Pharmacokinetics
- Sponsors Neumentum
- 04 Sep 2019 According to an Neumentum media release, this study is part of a program supporting what has the potential to be the first-ever NSAID approved for continuous infusion.
- 04 Sep 2019 Results published in the Neumentum Media Release.
- 04 Sep 2019 According to an Neumentum media release, the company announced that new results from this study will be presented at PAINWeek 2019.